Skip to content

Clinical trials

Terminated Phase 2 Hemoglobinuria, Paroxysmal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinuria, Paroxysmal Phase: Phase 2 Status: Terminated Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20191
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioCryst Pharmaceuticals4
Alexion Pharmaceuticals, Inc.1
Ra Pharmaceuticals, Inc.1
Roswell Park Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinuria, Paroxysmal7
Anemia, Aplastic1
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1
Granulomatous Disease, Chronic1
Hemolysis1
Immunologic Deficiency Syndromes1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Myeloid, Accelerated Phase1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.